Teo Helkkula, Gustav Christensen, Christian Ingvar, Karolin Isaksson, Katja Harbst, Bertil Persson, Åsa Ingvar, Anna Hafström, Ana Carneiro, Viktoria Gaspar, Göran Jönsson, Kari Nielsen
INTRODUCTION: Diagnosing invasive cutaneous melanoma (CM) can be challenging due to subjectivity in distinguishing equivocal nevi, melanoma in situ and thin CMs. The underlying molecular mechanisms of progression from nevus to melanoma must be better understood. Identifying biomarkers for treatment response, diagnostics and prognostics is crucial. Using biomedical data from biobanks and population-based healthcare data, translational research can improve patient care by implementing evidence-based findings...
February 2, 2024: BMJ Open